Re-analysis of ivermectin: When shaky science was removed, its Covid-19 benefits 'decreased' | Health24

South Africa News News

Re-analysis of ivermectin: When shaky science was removed, its Covid-19 benefits 'decreased' | Health24
South Africa Latest News,South Africa Headlines
  • 📰 News24
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 80%

Researchers re-evaluated studies on ivermectin for Covid-19 and found that when potential bias and medical fraud were removed, the drug had no significant benefit. | zakiyahebrahim Health24com

The controversy surrounding the use of ivermectin for the prevention and treatment of Covid-19 continues to rage across the globe.

When Dr Andrew Hill, from the University of Liverpool in England, and colleagues submitted a meta-analysis of ivermectin studies, the results appeared to be impressive and promising – so much so that it was widely cited by ivermectin proponents. But the same meta-analysis was later flagged after investigations revealed that one of its studies had"ethical concerns" and was potentially based on fraud, inconsistencies and plagiarism, Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism. You can cancel any time.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

News24 /  🏆 4. in ZA

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 LIVE UPDATES | SA records 24 new Covid-19 deaths as total cases near 3mCoronavirus live updates
Read more »

Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%Pfizer Inc's experimental antiviral pill to treat COVID-19 cut by 89% the chances of hospitalization or death for adults at risk of severe disease, the company said on Friday.
Read more »

Oxford scientists find gene that doubles risk of dying from Covid-19The findings help explain why higher rates of hospitalisation and death may have been seen in India
Read more »

Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%Pfizer Inc's experimental antiviral pill to treat COVID-19 cut by 89% the chances of hospitalization or death for adults at risk of severe disease, the company said on Friday.
Read more »



Render Time: 2025-04-02 14:09:35